In high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. But the transformation is just getting underway. By Steve Lohr Photographs by Spencer Lowell ...
Duxin Sun receives funding from the NIH, FDA, and pharmaceutical industries including Bristol-Myers Squibb, Celgene Corporation, Aurinia Pharmaceuticals, Abbvie, Nanomedicine Innovation Center.
Drug developers are seeking to speed up the testing and developing of new drugs with the help of artificial intelligence (AI). Researchers at universities and pharmaceutical giants are testing how AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results